![]() |
NEW YORK, April 24, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) President Lynn Martin congratulates Paul Atkins on being sworn in as the new Chairman of the Securities and Exchange Commission.
NYSE Content Advisory: Midday market update + NYSE President congratulates new SEC Chair Paul Atkins jwplayer(‘myplayer1’).setup(file: ‘https://mma.prnasia.com/media2/2672662/NYSE_Market_Update_Mid_Day_April_24.mp4’, image: ‘https://mma.prnasia.com/media2/2672662/NYSE_Market_Update_Mid_Day_April_24.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’);
Kristen Scholer delivers the pre-market update on April 24th
- NYSE President Lynn Martin, in a post on LinkedIn, congratulated SEC Chair Atkins after he was sworn in and expressed appreciation for his longstanding views on the markets.
- Martin emphasized the NYSE’s strong belief that “regulatory effectiveness and efficiency are central to the attractiveness of our markets,” adding that Chairman Atkins has been making that same argument since 2008.
- In her post, she wrote that she looks forward to working closely with Atkins and other policymakers in Washington D.C. to “create an environment that ensures our capital markets remain the envy of the world.”
- Stocks are gaining for a third straight session, extending a two-day rally boosted by a tone down in tariff talk and softer stance toward Federal Reserve Chair Jerome Powell.
Read NYSE President Lynn Martin’s Message Here
Download the NYSE TV App and Subscribe Here
Video – https://mma.prnasia.com/media2/2672662/NYSE_Market_Update_Mid_Day_April_24.mp4
ข่าวที่เกี่ยวข้อง
- Xinhua Silk Road: Jing’an District promotes investment opportunities, global business cooperation at 2026 CIIE
- Binance Blockchain Week Bangkok 2026 Unveils First Wave of Speakers, Spotlighting the Convergence of Traditional Finance and Digital Assets
- Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral Small Molecule Fixed-Dose Combination of GLP-1R Agonist and Selective Amylin Receptor Agonist, for the Treatment of Obesity
- Ali Y. Koç: ‘The Energy Transition Has Become the Cornerstone of Competitiveness in Industry’

